Package Leaflet: Information for the User
Cefuroxima SUN 500 mg film-coated tablets EFG
Cefuroxima (as cefuroxima axetil)
Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.
Contents of the pack
Cefuroxima is an antibiotic used in both adults and children. It works by killing the bacteria that cause infections. It belongs to a group of medicines called cephalosporins.
Antibiotics are used to treat bacterial infections and do not work for viral infections such as flu or the common cold.
It is important to follow the dosage, administration, and treatment duration instructions indicated by your doctor.
Do not store or reuse this medicine. If you have any leftover antibiotic after finishing the treatment, return it to the pharmacy for proper disposal. Do not throw away medicines via wastewater or household waste.
Cefuroxima is used to treat infections of:
Cefuroxima can also be used to:
Your doctor may analyze the type of bacteria that cause your infection and check if the bacteria are sensitive to Cefuroxima SUN during treatment.
Do not take Cefuroxima SUN:
If you think this applies to you, do not take Cefuroxima SUNuntil you have consulted your doctor.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Cefuroxima SUN.
Severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported with cefuroxima treatment. Seek immediate medical attention if you notice any of the symptoms related to these severe skin reactions described in section 4.
Children
Cefuroxima SUN is not recommended for children under 3 months, as safety and efficacy for this age group are unknown.
You should be aware of certain symptoms such as allergic reactions, fungal infections (such as Candida), and severe diarrhea (pseudomembranous colitis) while taking Cefuroxima SUN. This will reduce the risk of possible complications. See “Symptoms to be aware of”in section 4.
If you need a blood test
Cefuroxima SUN may affect the results of blood sugar tests or the Coombs test. If you need a blood test:
Taking Cefuroxima SUN with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Medicines used to reduce stomach acidity(e.g., antacidsto treat heartburn) may affect the action of Cefuroxima SUN.
Probenecid (a medicine used to treat gout)
Oral anticoagulants (medicines used to reduce blood clotting ability)
Tell your doctor or pharmacistif you are taking any of these medicines.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Cefuroxima SUN may cause dizzinessand other side effects that may make you lose alertness.
Do not drive or use machinesif you do not feel well.
Important information about some ingredients of Cefuroxima SUN
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially “sodium-free”.
Follow the administration instructionsof this medicineindicated by your doctoror pharmacist. If in doubt, consult your doctor or pharmacist again.
Take Cefuroxima SUN after meals.This will help make the treatment more effective.
Swallow the Cefuroxima SUN tablets whole with water.
Do not chew, crush, or divide the tablets— this may make the treatment less effective.
Recommended dose
Adults
The recommended dose of Cefuroxima SUN is 250 mg to 500 mg twice a day, depending on the severity and type of infection.
Children
The recommended dose of Cefuroxima SUN is 10 mg/kg of the child's weight (up to a maximum of 125 mg) to 15 mg/kg of the child's weight (up to a maximum of 250 mg) twice a day, depending on the severity and type of infection.
Cefuroxima SUNis not recommended in children under 3 months, as safety and efficacy for this age group are unknown.
Depending on the disease and how you or your child respond to treatment, the initial dose may be adjusted or it may be necessary to administer more than one treatment cycle.
Patients with kidney problems
If you have kidney problems, your doctor may change your dose.
Consult your doctor if you are affected by this problem.
If you take more Cefuroxima SUN than you should
If you take too much Cefuroxima SUN, you may experience neurological disorders, in particular, you may have a higher probability of having epileptic seizures (convulsions).
Do not delay.Contact your doctor immediately or go to the emergency department of the nearest hospital. If possible, show them the Cefuroxima SUN packaging.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Cefuroxima SUN
Do not take a double dose to make up for forgotten doses.Simply continue with the next dose as usual.
If you stop taking Cefuroxima SUN
Do not stop taking Cefuroxima SUN without prior advice.
It is important that you complete the entire treatment of Cefuroxima SUN.Do not stop it unless your doctor tells you to, even if you have started to feel better. If you do not complete the treatment cycle, the infection may recur.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Symptoms to be aware of
A small number of people who took Cefuroxima SUN experienced a severe allergic reaction or a potentially severe skin reaction. The symptoms of these reactions include:
Other symptoms to be aware of while taking Cefuroxima SUN include:
Common side effects(may affect up to 1 in 10 people):
Common side effects that may appear in blood tests:
Uncommon side effects(may affect up to 1 in 100 people):
Uncommon side effects that may appear in blood tests:
Other side effects
Other side effects have occurred in a very small number of people, but their exact frequency is unknown:
Side effects that may appear in blood tests:
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after the letters EXP. The expiry date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of via wastewater or household waste. Return the packaging and any unused medicine to the pharmacy's SIGRE point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Cefuroxima SUN
Core:
Microcrystalline cellulose (PH101), microcrystalline cellulose (PH112), sodium croscarmellose, sodium lauryl sulfate, hydrogenated vegetable oil, anhydrous colloidal silica.
Coating:
Opadry White OY-S-58910 (contains hypromellose (E464), titanium dioxide (E171), macrogol (E1521), talc (E553b)).
Appearance of the product and pack contents
White to almost white film-coated tablets, capsule-shaped, smooth on one side and engraved with "500" on the other. The tablets are 18.0 mm long, 9.0 mm wide, and 6.95 mm thick. Each box contains 6, 10, 12, 14, 15, 20, 24, 30, 50, 100, 120, or 500 tablets (clinical packaging) in PVC/ACLAR/Aluminum blisters.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Sun Pharmaceutical Industries Europe B.V.
Polarisavenue 87
2132JH Hoofddorp
Netherlands
Manufacturer
Alkaloida Chemical Company Zrt.
4400 Tiszavasvári
Kabay János u.29
Hungary
or
Terapia, S.A.
124, Fabricii Street
400 632 – Cluj Napoca
Romania
or
SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.
Polarisavenue, 87 - Hoofddorp - 2132 JH - Netherlands
Local representative
Sun Pharma Laboratorios, S.L.
Rambla de Catalunya, 53-55
08007 Barcelona, Spain
Phone: +34 93 342 78 90
This medicine is authorized in the Member States of the European Economic Area under the following names:
Netherlands: Cefuroxim SUN 250 mg film-coated tablets
Cefuroxim SUN 500 mg film-coated tablets
Czech Republic: Znobact 500 mg film-coated tablets
Hungary: Ceroxim 250 mg (500 mg) film-coated tablets
Germany: CEFUROX BASICS 250mg (500mg) film-coated tablets
Poland: Ceroxim
Slovakia: Cefuroxim SUN 500 mg film-coated tablets
Spain: Cefuroxima SUN film-coated tablets EFG
Date of last revision of this leaflet:May 2023
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es
The average price of CEFUROXIME SUN 500 mg FILM-COATED TABLETS in October, 2025 is around 9.68 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.